Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Elvira Bailón"'
Autor:
Alejandra Gutiérrez-González, Noemí Aguilera-Montilla, Estefanía Ugarte-Berzal, Elvira Bailón, Isabel Cerro-Pardo, Clara Sánchez-Maroto, Lara García-Campillo, José A. García-Marco, Angeles García-Pardo
Publikováno v:
Blood Advances, Vol 3, Iss 14, Pp 2144-2148 (2019)
Externí odkaz:
https://doaj.org/article/746904a9a0ee4fd6bb4630545a015d9a
Autor:
Elvira Bailón, Juan Román, Isabel Ramis, Pedro Michelena, Dolors Balsa, Manuel Merlos, Antonio Zarzuelo, Julio Gálvez, Mònica Comalada
Publikováno v:
Journal of Pharmacological Sciences, Vol 109, Iss 2, Pp 315-318 (2009)
The aim of the present study was to evaluate the inmunomodulatory effects of UR-1505, a new salicylate derivative, on the T helper (Th)2 / humoral response produced during dextran sodium sulfate (DSS)-induced rat colitis. In the in vitro studies, UR-
Externí odkaz:
https://doaj.org/article/3bd372bc9ae4413bb44c5924ef51f0b6
Autor:
Irene Amigo-Jiménez, Elvira Bailón, Estefanía Ugarte-Berzal, Noemí Aguilera-Montilla, José A García-Marco, Angeles García-Pardo
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99993 (2014)
BackgroundMatrix metalloproteinase-9 (MMP-9) contributes to chronic lymphocytic leukemia (CLL) pathology by regulating cell migration and preventing spontaneous apoptosis. It is not known if MMP-9 is involved in CLL cell response to chemotherapy and
Externí odkaz:
https://doaj.org/article/2cebfa6706cf4c8e9f6b47ea8fab24e6
Autor:
Cristina Pérez-Sánchez, Estefania Ugarte-Berzal, Ghislain Opdenakker, Philippe E. Van den Steen, Noemí Aguilera-Montilla, Alejandra Gutiérrez-González, Angeles García-Pardo, Rebeca Uceda-Castro, José A. García-Marco, Andrea Santos, Elvira Bailón
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
58 p.-8 fig.-6 tab. supl.
We previously showed that MMP-9 contributes to CLL pathology by regulating cell survival and migration and that, when present at high levels, MMP-9 induces cell arrest. To further explore the latter function, we studied
We previously showed that MMP-9 contributes to CLL pathology by regulating cell survival and migration and that, when present at high levels, MMP-9 induces cell arrest. To further explore the latter function, we studied
Autor:
Angeles García-Pardo, Alejandra Gutiérrez-González, Noemí Aguilera-Montilla, José A. García-Marco, Estefania Ugarte-Berzal, Ghislain Opdenakker, Elvira Bailón, Philippe E. Van den Steen
Publikováno v:
Biochemical and Biophysical Research Communications. 495:124-130
We previously showed that MMP-9 overexpression impairs migration of primary CLL cells and MEC-1 cells transfected with MMP-9. To determine the contribution of non-proteolytic activities to this effect we generated MEC-1 transfectants stably expressin
Autor:
Philippe E. Van den Steen, Ghislain Opdenakker, Noemí Aguilera-Montilla, Angeles García-Pardo, José A. García-Marco, Rafael Samaniego, Rebeca Uceda-Castro, Elena García-Martínez, María Prieto-Solano, Elvira Bailón, Estefania Ugarte-Berzal
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
27 p.-3 fig.-2 tab.
Increased angiogenesis is commonly observed in chronic lymphocytic leukemia (CLL) tissues in correlation with advanced disease. CLL cells express pro- and anti-angiogenic genes and acquire a pro-angiogenic pattern upon intera
Increased angiogenesis is commonly observed in chronic lymphocytic leukemia (CLL) tissues in correlation with advanced disease. CLL cells express pro- and anti-angiogenic genes and acquire a pro-angiogenic pattern upon intera
Autor:
Clara Sánchez-Maroto, Angeles García-Pardo, José A. García-Marco, Estefania Ugarte-Berzal, Lara García-Campillo, Alejandra Gutiérrez-González, Elvira Bailón, Isabel Cerro-Pardo, Noemí Aguilera-Montilla
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
5 p.-2 fig.
In chronic lymphocytic leukemia (CLL), α4β1 integrin (the main α4 heterodimer in CLL) and vascular endothelial growth factor (VEGF) share several pathological properties, including involvement in cell migration and survival.Accord
In chronic lymphocytic leukemia (CLL), α4β1 integrin (the main α4 heterodimer in CLL) and vascular endothelial growth factor (VEGF) share several pathological properties, including involvement in cell migration and survival.Accord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63878095970337ecf6dd998b008f8ff4
http://hdl.handle.net/10261/186469
http://hdl.handle.net/10261/186469
Autor:
Noemí Aguilera-Montilla, José A. García Marco, Elvira Bailón, Angeles García-Pardo, Irene Amigo-Jiménez
Publikováno v:
Oncotarget
Digital.CSIC. Repositorio Institucional del CSIC
instname
Digital.CSIC. Repositorio Institucional del CSIC
instname
19 p.-9 fig.-1 tab.
CLL remains an incurable disease in spite of the many new compounds being tested. Arsenic trioxide (ATO) induces apoptosis in all CLL cell types and could constitute an efficient therapy. To further explore this, we have stud
CLL remains an incurable disease in spite of the many new compounds being tested. Arsenic trioxide (ATO) induces apoptosis in all CLL cell types and could constitute an efficient therapy. To further explore this, we have stud
Autor:
Noemí Aguilera-Montilla, Angeles García-Pardo, María José Terol, José A. García-Marco, Irene Amigo-Jiménez, Elvira Bailón
Publikováno v:
Oncotarget
CLL remains an incurable disease in spite of the many new compounds being studied. Arsenic trioxide (ATO) induces apoptosis in all CLL cell types and could constitute an efficient therapy. To further explore this, we have studied the influence of str
Autor:
Norma C. Gutiérrez, Ana Dios-Esponera, Javier Redondo-Muñoz, David García-Bernal, Elvira Bailón, Raphael Chevre, Mercedes Garayoa, Nohemí Arellano-Sánchez, Andrés Hidalgo, Angeles García-Pardo, Joaquin Teixidó
Publikováno v:
The Journal of Pathology. 229:36-48
Myeloma cell adhesion dependent on α4β1 integrin is crucial for the progression of multiple myeloma (MM). The α4β1-dependent myeloma cell adhesion is up-regulated by the chemokine CXCL12, and pharmacological blockade of the CXCL12 receptor CXCR4